- ASSISTANT PROFESSOR Oncological Sciences
- ASSISTANT PROFESSOR Psychiatry
BA, University of Pennsylvania
M.A., St. John's University
Ph.D., St John's University
Postdoctoral Fellowship, Mount Sinai School of Medicine, Oncological Sciences
Internship, Clinical Psychology
Nassau University Medical Center
- I am an Assistant Professor in the Department of Oncological Sciences (with a secondary appointment in Psychiatry), Co-Director of the Integrative Behavioral Medicine Program and a licensed clinical psychologist. My overall program of research is focused on understanding patients’ experiences of cancer treatment and developing psychological interventions to help improve their cancer treatment experiences. My clinical work is focused on helping to improve the well-being of women with breast cancer being treated at the Dubin Breast Center, from diagnosis through survivorship. I incorporate both traditional psychotherapeutic approaches (e.g., cognitive-behavioral therapy) and complementary mind-body approaches (e.g., hypnosis) into my work with patients. I am available to help patients with problem-solving, stress management, managing treatment side effects such as pain and fatigue, adjusting to cancer-related changes, transitioning to survivorship, enhancing wellness, and provide support throughout the cancer journey.
2015 - 2018
Development of Sun Protection Barriers and Facilitators Scale in Spanish
2015 - 2019
Psychosocial Intervention for Advanced Lung Cancer Patients and Caregivers
2015 - 2020
Hypnosis to reduce aromatase inhibitor (AI)-associated musculoskeletal pain and to improve AI adherence: An RCT to explore clinical efficacy and cost effects.
2014 - 2016
Cancer treatment retraumatization in sexual abuse survivors
2014 - 2019
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
Early Career Contribution Award
St. John’s University
Dr. Harold and Golden Lamport Research Award
Icahn School of Medicine at Mount Sinai
Roy M. Dorcus Award for Best Clinical Paper
The Society for Clinical and Experimental Hypnosis
2012 - 2017
E-counseling in Psychosocial Cancer Care: A Competency-Based E-learning Approach
2010 - 2015
Cancer Prevention & Control: Multidisciplinary Training
The Society of Psychological Hypnosis
Cancer-related quality of life, Psychosocial issues in cancer, healthcare retraumatizationMy program of research involves: 1) understanding aspects of cancer patients’ distress and healthcare preferences which are under-recognized in the scientific literature (using both qualitative and quantitative approaches); 2) developing new patient-reported outcome measures; and, 3) developing and testing psychotherapeutic interventions to improve cancer-related quality of life. My current research focus is understanding cancer treatment as a source of retraumatization for survivors of childhood sexual abuse. For sexual abuse survivors, even routine cancer care can feel intrusive and violating, can trigger memories of abuse, and can lead to healthcare avoidance. Yet, to date, there has been no empirical study of cancer treatment retraumatization in sexually abused cancer (SACA) patients. My NCI-funded R21 aims to address this gap in the literature. Additionally, I work with radiation oncology staff to develop and test the feasibility of new online tools to prepare patients for radiotherapy treatment, assess patient preferences, and facilitate patient-centered care. Finally, I collaborate on projects involving: hypnosis to treat musculoskeletal pain in breast cancer survivors taking aromatase inhibitors, E-therapy in psychosocial cancer care, the development of a sun protection barriers and facilitators scale, psychosocial interventions in the lung cancer setting, and how clinical and genetic data can be integrated to give breast cancer patients more accurate information about their individual risk of radiation side-effects.
Montgomery GH, David D, Kangas M, Green S, Sucala M, Bovbjerg DH, Hallquist MN, Schnur JB. Randomized controlled trial of a cognitive-behavioral therapy plus hypnosis intervention to control fatigue in patients undergoing radiotherapy for breast cancer. Journal of Clinical Oncology 2014 Feb; 32(6): 557-63.
Sucala M, Schnur JB, Brackman EH, Constantino MJ, Montgomery GH. Clinicians' attitudes toward therapeutic alliance in E-therapy. The Journal of General Psychology 2013 Oct-Dec; 140(4): 282-93.
Sucala M, Schnur JB, Glazier K, Miller SJ, Green JP, Montgomery GH. Hypnosis--there's an app for that: a systematic review of hypnosis apps. The International Journal of Clinical and Experimental Hypnosis 2013; 61(4): 463-74.
Montgomery GH, Schnur JB, Kravits K. Hypnosis for cancer care: over 200 years young. CA: A Cancer Journal for Clinicians 2013 Jan; 63(1): 31-44.
Schnur JB, Graff Zivin J, Mattson DM, Green S, Jandorf LH, Wernicke AG, Montgomery GH. Acute skin toxicity-related, out-of-pocket expenses in patients with breast cancer treated with external beam radiotherapy: a descriptive, exploratory study. Supportive Care in Cancer 2012 Dec; 20(12): 3105-13.
Schnur JB, Goldsmith RE. Through her eyes. Journal of Clinical Oncology 2011 Oct; 29(30): 4054-6.
Schnur JB, Ouellette SC, Dilorenzo TA, Green S, Montgomery GH. A qualitative analysis of acute skin toxicity among breast cancer radiotherapy patients. Psycho-oncology 2011 Mar; 20(3): 260-8.
Schnur JB, Love B, Scheckner BL, Green S, Wernicke AG, Gabriella A, Montgomery GH. A systematic review of patient-rated measures of radiodermatitis in breast cancer radiotherapy. American Journal of Clinical Oncology 2011 Oct; 34(5): 529-36.
Schnur JB. Radiotherapy-induced skin changes and quality of life. The Lancet. Oncology 2010 Mar; 11(3): 212.
Schnur JB, Montgomery GH. A systematic review of therapeutic alliance, group cohesion, empathy, and goal consensus/collaboration in psychotherapeutic interventions in cancer: Uncommon factors?. Clinical Psychology Review 2010 Mar; 30(2): 238-47.
Montgomery GH, Kangas M, David D, Hallquist MN, Green S, Bovbjerg DH, Schnur JB. Fatigue during breast cancer radiotherapy: an initial randomized study of cognitive-behavioral therapy plus hypnosis. Health Psychology 2009 May; 28(3): 317-22.
Schnur JB, Ouellette SC, Bovbjerg DH, Montgomery GH. Breast cancer patients' experience of external-beam radiotherapy. Qualitative Health Research 2009 May; 19(5): 668-76.
Schnur JB, David D, Kangas M, Green S, Bovbjerg DH, Montgomery GH. A randomized trial of a cognitive-behavioral therapy and hypnosis intervention on positive and negative affect during breast cancer radiotherapy. Journal of Clinical Psychology 2009 Apr; 65(4): 557-63.
Schnur JB, Kafer I, Marcus C, Montgomery GH. Hypnosis to manage distress related to medical procedures: A meta-analysis. Contemporary Hypnosis 2008 Aug; 25(3-4): 114-128.
Schnur JB, Bovbjerg DH, David D, Tatrow K, Goldfarb AB, Silverstein JH, Weltz CR, Montgomery GH. Hypnosis decreases presurgical distress in excisional breast biopsy patients. Anesthesia and Analgesia 2008 Feb; 106(2): 440-4.
Montgomery GH, Bovbjerg DH, Schnur JB, David D, Goldfarb A, Weltz CR, Schechter C, Graff-Zivin J, Tatrow K, Price DD, Silverstein JH. A randomized clinical trial of a brief hypnosis intervention to control side effects in breast surgery patients. Journal of the National Cancer Institute 2007 Sep; 99(17): 1304-12.
Schnur JB, Valdimarsdottir HB, Montgomery GH, Nevid JS, Bovbjerg DH. Social constraints and distress among women at familial risk for breast cancer. Annals of Behavioral Medicine 2004 Oct; 28(2): 142-8.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Schnur did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
1425 Madison Avenue
New York, NY 10029
Icahn Medical Institute Floor 4 Room 4-80B
1425 Madison Avenue
New York, NY 10029
Icahn Medical Institute Floor 4 Room 4-80
1425 Madison Avenue
New York, NY 10029
1176 Fifth Avenue, First Floor
New York, NY 11029